Products and Services

Products and Services

Active Pharmaceutical Ingredients


Ausun

Product Name

CAS Number

Specification

DMF

CEP

Status

CN

PV

(Ruxolitinib phosphate)

941678-49-5&1092939-17-7

In-house

√

A

(琥珀酸)瑞波西利

1211441-98-3 & 1374639-75-4

In-house

Q4 2026

Tepotinib

1946826-82-9

In-house

Q1 2027

Ivacaftor

873054-44-5

In-house

√

Sodium Sulfadiazine

163253-35-8

203787-91-1

√

Tofacitinib Citrate

540737-29-9

In-house

√

A

Perfluorohexane

133331-77-8

In-house

Q4 2026

Bimatoprost

155206-00-1

In-house

√

I

Cabozantinib

849217-68-1

In-house

√

Bemimetinib

606143-89-9

In-house

√

I

Ibrutinib

936563-96-1

In-house

√

I

Trametinib

871700-17-3

In-house

√

I

Venetoclax

1257044-40-8

√

Bulver peptide

2012558-47-1

Q2 2027

Q2 2027 Q4 2027

Enlyxipide Decanoate

2861205-06-1

Q3 2027

Q1 2028

Etacapine Hydrochloride

1334237-71-6

Q4 2026

Completed

Icobilactone hydrochloride

2763602-16-8

Q1 2027

Q3 2027

Inosine sodium

1639324-58-5

Q2 2027

Q4 2027

Lanreotide acetate

127984-74-1

Completed

Q1 2027

Semaglutide

1504602-49-6

Q4 2026

Q2 2027